Silence Therapeutics (SLN) Non-Current Deffered Revenue (2023 - 2026)
Silence Therapeutics (SLN) reported Non-Current Deffered Revenue of $55.22 million for the quarter ended Jun 30, 2026, down 1.9% from $56.31 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Silence Therapeutics (SLN) Non-Current Deffered Revenue (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Silence Therapeutics posted Non-Current Deffered Revenue of $55.45 million, up 7.1% from the prior year.
- By year, Non-Current Deffered Revenue came in at $51.79 million in the year ended Dec 31, 2024 (-30.9%) and $75 million in the year ended Dec 31, 2023.
- Five-year quarterly Non-Current Deffered Revenue spans a low of $51.79 million in the quarter ended Dec 31, 2024 and a high of $75 million in the quarter ended Dec 31, 2023.
- Year over year, Non-Current Deffered Revenue gained in two of the last four quarters, with an average decline of 5.5%.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $55.22 million (quarter ended Mar 31, 2026), $55.45 million (quarter ended Dec 31, 2025) and $55.25 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Silence Therapeutics | 516.41 Mn | 444.31 Mn | - | 55.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.22 Mn |
| Mar 31, 2026 | 55.22 Mn |
| Dec 31, 2025 | 55.45 Mn |
| Sep 30, 2025 | 55.25 Mn |
| Jun 30, 2025 | 56.31 Mn |
| Mar 31, 2025 | 53.29 Mn |
| Dec 31, 2024 | 51.79 Mn |
| Dec 31, 2023 | 75.00 Mn |
API Access
Silence Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();